The high price of cancer drugs: enough is enough.
In 2013, a group of about a hundred oncologists from around the world spoke out against the soaring prices of tyrosine kinase inhibitors, pointing out that unaffordable drug prices prevent many patients from accessing treatment. A study conducted in 2009 showed that France's expenditure on certain cancer drugs was the highest in Europe.
D000970:Antineoplastic Agents / Q000191:economics*; D016527:Drug Costs; D005602:France; D005102:Health Expenditures; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans
D000970:Antineoplastic Agents